Ionic mechanisms of electrical remodeling in human atrial fibrillation

Cardiovascular Research

Volumn 44, Issue 1, 1999, Pages 121-131

  Bosch, Ralph F ^a   Zeng, Xiaorong ^a   Grammer, Joachim B ^a   Popovic, Katarina ^a   Mewis, Christian ^a   Kühlkamp, Volker ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Arrhythmia (mechanisms); Ca channel; Cellular; Electrophysiology; Experimental; Heart; Ion channels; K channel; Na channel

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ION CHANNEL; NITRIC ACID DERIVATIVE; POTASSIUM CHANNEL; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HUMAN; ION CONDUCTANCE; ION CURRENT; MALE; MEMBRANE STEADY POTENTIAL; PATCH CLAMP; PRIORITY JOURNAL; SINUS RHYTHM;

ACETYLCHOLINE; ACTION POTENTIALS; AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; ELECTRIC STIMULATION; FEMALE; HUMANS; ION CHANNELS; MALE; MIDDLE AGED; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; SODIUM CHANNELS;

EID: 0033213925     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00178-9     Document Type: Article

References (46)

1. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 306:1982;1018-1022.
2. Atrial fibrillation. Current understandings and research imperatives. J Am Coll Cardiol. 22:1993;1830-1834.
3. Halperin J.L., Hart R.G. Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke. 19:1988;937-941.
4. Wolf P.A., Dawber T.R., Thomas H.E., Kannel W.B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 28:1978;973-977.
5. Cairns J.A., Connelly S.J. Nonrheumatic atrial fibrillation: risk of stroke and antithrombotic therapy. Circulation. 84:1991;469-481.
6. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A.L., Cuddy T.E.D. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med. 98:1995;476-484.
7. Wijffels M.C.E.F., Kirchhof C.J.H.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation: a study in awake, chronically instrumented goats. Circulation. 92:1995;1954-1968.
8. Morillo C.A., Klein G.J., Jones D.L., Guiraudon C.M. Chronic rapid atrial pacing: structural, functional and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 91:1995;1588-1595.
9. Gaspo R., Bosch R.F., Talajic M., Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation. 96:1997;4027-4035.
10. Elvan A., Wylie K., Zipes D.P. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs - Electrophysiological remodeling. Circulation. 94:1996;2953-2960.
11. Kumagai K., Akimitsu S., Kawahira K., et al. Electrophysiological properties in chronic lone atrial fibrillation. Circulation. 84:1991;1662-1668.
12. Daoud E.G., Bogun F., Goyal R., et al. Effects of atrial fibrillation on atrial refractoriness in humans. Circulation. 94:1996;1600-1606.
13. Misier A.R., Opthof T., van-Hemel N.M., et al. Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol. 19:1992;1531-1535.
14. Zhang S., Sawanobori T., Hirano Y., Hiraoka M. Multiple modulations of action potential duration by different calcium channel blocking agents in guinea pig ventricular myocytes. J Cardiovasc Pharmacol. 30:1997;489-496.
15. Allessie M.A. Reentrant mechanisms underlying atrial fibrillation. Zipes D.P., Jalife J. Cardiac electrophysiology - From cell to bedside. 1995;562-566 Saunders, Philadelphia.
16. Yue L., Feng J., Gaspo R., et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 81:1997;512-525.
17. + current in a chronic dog model of atrial fibrillation. Circ Res. 81:1997;1045-1052.
18. + current densities and Kv1.5 Expression are reduced in chronic human atrial fibrillation. Circ Res. 80:1997;772-781.
19. Escande D., Coulombe A., Faivre J.F., Deroubaix E., Corabouef E. Two types of transient outward currents in adult human atrial cells. Am J Physiol. 252:1987;H142-H148.
20. + current similar to Kv1.5 cloned channel currents. Circ Res. 73:1993;1061-1076.
21. + channel current. Circ Res. 73:1993;210-216.
22. + channel in human cardiac myocytes. Circulation. 92:1995;164-174.
23. Heidbüchel H., Vereecke J., Carmeliet E. The electrophysiological effects of acetycholine in single human atrial cells. J Mol Cell Cardiol. 19:1987;1207-1219.
24. Bosch R.F., Milek I.V., Popovic K., et al. Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium. J Cardiovasc Pharmacol. 289:1999;156-165.
25. 2+ antagonists and agonists in rabbit cardiac myocytes. Am J Physiol. 260:1991;H1737-H1742.
26. Li G.R., Nattel S. Properties of human atrial ICa at physiological temperatures and relevance to action potential. Am J Physiol. 272:1997;H227-H235.
27. Wang Y.G., Schreieck J., Weyerbrock S., Overbeck M., Meisner H. Unterschiedlicher transienter Auswärtsstrom (Ito) in atrialen Kardiomyozyten von Patienten mit und ohne Herzinsuffizienz. Z Kardiol. 87:1998;125. (Abstract).
28. Wegener J.W., Nawrath H. Action of tertiary phenylalkylamines on cardiac transient outward current from outside the cell membrane. Naunyn Schmiedebergs Arch Pharmacol. 354:1996;746-754.
29. Yue L., Feng J., Li G.R., Nattel S. Characterization of an ultrarapid delayed rectifier potassium channel involved in canine atrial repolarization. J Physiol Lond. 496:1996;647-662.
30. + channel blockers and muscarinic receptor stimulation. J Pharmacol Exp Ther. 273:1995;1095-1104.
31. Visentin S., Wu S.N., Belardinelli L. Adenosine-induced changes in atrial action potential: contribution of Ca- and K-currents. Am J Physiol. 258:1990;H1070-H1078.
32. Allessie R., Nusynowitz M., Abildskov J.A., Moe G.K. Non-uniform distribution of vagal effects on atrial refractory period. Am J Physiol. 194:1958;406-410.
33. Allessie M.A., Lammers W.J., Bonke I.M., Hollen J. Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in the dog. Circulation. 70:1984;123-135.
34. Coumel P. Role of the autonomic nervous system in paroxysmal atrial fibrillation. Clin Cardiol. 13:1990;209-212.
35. Waxman M.B., Cameron D.A., Wald R.W. Interactions between the autonomic nervous system and supraventricular tachycardia in humans. Zipes D.P., Jalife J. Cardiac electrophysiology: from cell to bedside. 1995;699-722 W.B. Saunders Company, Philadelphia.
36. Pu J., Shvilkin A., Hara M., Danilo P., Boyden P.A. Altered inward currents in myocytes from chronically fibrillating canine atria. Circulation. 96:1997;1-180. (abstract).
37. Van Wagoner D.R., Lamorgese M., Kirian P. Calcium current density is reduced in atrial myocytes isolated from patients in chronic atrial fibrillation. Circulation. 96:1997;1-180. (abstract).
38. Pressler M., Munster P., Huang C.D. Gap junction distribution in the heart: functional relevance. Zipes D., Jalife J. Cardiac electrophysiology: from cell to bedside. 1995;144-151 W.B. Saunders, Philadelphia, PA.
39. Spach M.S., Starmer C.F. Altering the topology of gap junctions, a major therapeutic target for atrial fibrillation. Cardiovasc Res. 30:1995;337-344.
40. Elvan A., Huang X.D., Pressler M.L., Zipes D.P. Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs. Circulation. 96:1997;1675-1685.
41. van derVelden H.M.W., van Kempen M.J.A., Wijffels M.C.E.F., et al. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol. 9:1998;596-607.
42. Patel P., Jones D.G., Dupont E. Remodelling of atrial connexin43 expression in human atrial fibrillation. Eur Heart J. 19:1998;465. (Abstract).
43. Yue L., Wang Z., Gaspo R., Nattel S. The molecular mechanism of ionic remodeling of repolarization in a dog model of atrial fibrillation. Circulation. 96:1997;1-180. (abstract).
44. Brundel B.J., Van Gelder I.C., Hennings R.H. Downregulation of the mRNA expression of L-type calcium channel and acetylcholine-activated potassium channel in chronic atrial fibrillation. Eur Heart J. 18:1997;193. (abstract).
45. Yue L., Feng J., Li G.R., Nattel S. Transient outward and delayed rectifier currents in canine atrium. properties and role of isolation methods. Am J Physiol. 270:1996;H2157-H2168.
46. Nattel S., Hadjis T., Talajic M. The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs. 48:1994;345-371.